Trial Finds Remdesivir As Beneficial COVID-19 Drug, NIH Says

Watch VideoThe National Institutes of Health says drug trials are showing remdesivir may offer significant benefits for coronavirus patients who don't require ventilation.

The NIH says the drug cut the recovery time of patients by four days when compared to patients receiving a placebo, according to a study published in the...